Every NR4A2 paper, in plain English

Loss of PHF6 causes spontaneous seizures, enlarged brain ventricles and altered transcription in the cortex of a mouse model of the Börjeson-Forssman-Lehmann intellectual disability syndrome.

McRae HM, Leong MPY, Bergamasco MI, Garnham AL, Hu Y, Corbett MA, Whitehead L, El-Saafin F, Sheikh BN, Wilcox S, Hannan AJ, Gécz J, Smyth GK, Thomas T, Voss AK

This study investigates Börjeson-Forssman-Lehmann syndrome, a different genetic condition caused by PHF6 mutations, rather than NR4A2-related syndrome. It identifies that loss of the PHF6 protein leads to seizures and altered brain development in mice through specific molecular pathways. The research does not provide direct evidence or treatment insights for children with NR4A2 variants.

• The paper studies PHF6 mutations, not NR4A2, making it genetically distinct from the child's condition.
• Loss of PHF6 causes spontaneous seizures and enlarged brain ventricles in mouse models.
• PHF6 deficiency alters gene expression, including upregulation of Nr4a2, but this is incidental to the primary disease mechanism.
• The findings describe a different neurodevelopmental disorder with no direct clinical application for NR4A2 syndrome.

Differential roles of NR4A2 (NURR1) paralogs in the brain and behavior of zebrafish.

Kalyn M, Garvey R, Lee H, Mbesha HA, Curry J, Saxena V, Mennigen JA, Ekker M

This study uses zebrafish models to distinguish the specific roles of two NR4A2 gene copies, showing that one copy primarily drives dopamine neuron health while the other influences behavior and metabolism. The findings clarify how NR4A2 dysfunction affects dopamine pathways but do not provide direct evidence for human treatment strategies.

• Zebrafish have two NR4A2 copies with distinct functions in dopamine neurons and behavior.
• Loss of one copy mimics Parkinsonian symptoms and reduces neurotrophic factors.
• Loss of the other copy alters metabolism and increases reactive oxygen species.
• Results help map molecular mechanisms but offer no immediate clinical guidance.

Identification and validation of diagnostic markers related to immunogenic cell death and infiltration of immune cells in diabetic nephropathy.

Jin D, Tu X, Xu W, Zheng H, Zeng J, Bi P, Yang R, Li Y, Ni J, Zhu C, Chen H, Yu D, Wan F

This study identifies NR4A2 as one of several genes associated with diabetic nephropathy, a kidney disease unrelated to the neurological symptoms of NR4A2 syndrome. The research focuses on immune system mechanisms in kidney tissue and does not provide insights into brain development or treatment for NR4A2-related conditions.

• NR4A2 appears as a marker in diabetic nephropathy, not NR4A2 syndrome.
• The study analyzes kidney biopsies and immune cell infiltration.
• No findings relate to dopaminergic neurons or neurodevelopment.
• Results do not inform clinical management for NR4A2 children.

Author Correction: CB2 receptor activation inhibits the phagocytic function of microglia through activating ERK/AKT-Nurr1 signal pathways.

Han QW, Shao QH, Wang XT, Ma KL, Chen NH, Yuan YH

Activating CB2 receptors suppresses microglial immune activity by triggering a signaling pathway that involves the protein Nurr1. This mechanism suggests potential for modulating neuroinflammation, though it does not address NR4A2 genetic mutations or developmental outcomes in children.

• CB2 receptor activation reduces microglia phagocytosis via ERK/AKT-Nurr1 signaling.
• The study focuses on immune modulation, not NR4A2 gene function or therapy.
• No human clinical data or relevance to NR4A2 syndrome phenotypes is presented.

Fam3a-mediated prohormone convertase switch in α-cells regulates pancreatic GLP-1 production in an Nr4a2-Foxa2-dependent manner.

Wang D, Wei T, Cui X, Xia L, Jiang Y, Yin D, Liao X, Li F, Li J, Wu Q, Lin X, Lang S, Le Y, Yang J, Yang J, Wei R, Hong T

This study identifies a molecular pathway in mouse pancreatic cells where the protein Fam3a regulates GLP-1 production through Nr4a2 and Foxa2. The findings demonstrate that removing Fam3a increases GLP-1 levels, which improves glucose tolerance and insulin secretion in diabetic mice.

• Fam3a deficiency increases active GLP-1 production in mouse pancreatic alpha cells.
• Nr4a2 acts as a downstream mediator in the Fam3a-Foxa2 regulatory pathway.
• Increased GLP-1 improves glucose tolerance and insulin response in diabetic mice.
• The mechanism involves reprogramming proglucagon processing from glucagon to GLP-1.

Transcriptomic Profiling of Primary Microglia: Effects of miR-19a-3p and miR-19b-3p on Microglia Activation.

Sahebdel F, Zia A, Quinta HR, Morse LR, Olson JK, Battaglino RA

This study uses mouse microglia to show that specific microRNAs drive neuroinflammation by targeting transcription factors, including NR4A2. It identifies NR4A2 as a key regulator in inflammatory pathways but provides no data on human patients or treatments for NR4A2-related syndromes. The findings are limited to basic molecular mechanisms of pain and inflammation in mice.

• Researchers studied mouse microglia cells to understand neuroinflammation after spinal cord injury.
• MicroRNAs miR-19a and miR-19b regulate inflammatory gene expression in these cells.
• NR4A2 is identified as a transcription factor targeted by miR-19b in this pathway.
• The study focuses on pain mechanisms, not NR4A2 syndrome or human genetics.
• No clinical data, patient cohorts, or therapeutic interventions are reported.

Identification of key hub genes in knee osteoarthritis through integrated bioinformatics analysis.

Xu L, Ma J, Zhou C, Shen Z, Zhu K, Wu X, Chen Y, Chen T, Lin X

This study identifies NR4A2 as one of the top hub genes linked to knee osteoarthritis, a condition involving joint inflammation and cartilage damage. The gene is associated with immune cells like macrophages and T follicular helper cells, and Mendelian randomization suggests it may influence disease risk. These findings could help develop early diagnostic tools for joint disease.

• NR4A2 is a top hub gene in knee osteoarthritis
• NR4A2 correlates with immune cells involved in joint inflammation
• Genes including NR4A2 may predict disease risk
• Findings could lead to early diagnostic tests
• NR4A2 is linked to the IL-17 inflammatory pathway

Prostaglandin E2 signaling through prostaglandin E receptor subtype 2 and Nurr1 induces fibroblast growth factor 23 production.

Feger M, Hammerschmidt K, Liesche I, Rausch S, Alber J, Föller M

Prostaglandin E2 signaling through the EP2 receptor and Nurr1 increases production of FGF23, a hormone that regulates phosphate and vitamin D levels. This mechanism was observed in bone cells and confirmed in mouse models where activating this pathway raised FGF23 levels.

• PGE2 activates EP2 receptors to boost FGF23 production via Nurr1.
• Mouse studies show EP2 activation raises serum FGF23 levels significantly.
• FGF23 regulates renal phosphate and vitamin D homeostasis.
• EP2 deficiency blunts the FGF23 response to PGE2 signaling.

Role of Elavl-like RNA-binding protein in retinal development and signal transduction.

Wutikeli H, Yu Y, Zhang T, Cao J, Nawy S, Shen Y

This study investigates how specific RNA-binding proteins regulate retinal development and visual function in mice, with no direct application to NR4A2-related syndromes. The research focuses on Elavl2 and Elavl4 mechanisms in the eye rather than the neurological or developmental impacts of NR4A2 variants.

• Study uses mouse models, not human patients or clinical data.
• Focuses on retinal amacrine cell differentiation and vision.
• Elavl2 interacts with GABAB receptors in the retina.
• No findings related to NR4A2 haploinsufficiency or treatment.
• Preclinical molecular biology with no stated clinical line.

Claustrum and dorsal endopiriform cortex complex cell-identity is determined by Nurr1 and regulates hallucinogenic-like states in mice.

Mantas I, Flais I, Masarapu Y, Ionescu T, Frapard S, Jung F, Le Merre P, Saarinen M, Tiklova K, Salmani BY, Gillberg L, Zhang X, Chergui K, Carlén M, Giacomello S, Hengerer B, Perlmann T, Svenningsson P

Nurr1 determines the identity of neurons in a specific brain region called the claustrum and regulates how mice respond to hallucinogens. Removing Nurr1 from these neurons eliminates hallucinogen receptor signaling and alters brain connectivity patterns associated with drug effects.

• Nurr1 is essential for establishing the genetic identity of claustrum neurons.
• Loss of Nurr1 abolishes hallucinogen receptor expression in this brain region.
• Nurr1 absence changes how hallucinogens affect connectivity between cortical areas.
• The study uses mouse models to explore claustrum function and drug response.

[IDI2-AS1 influences the development of acute myocardial infarction by regulating NR4A2 through microRNA-33b-5p].

Wu S, Pang Z, Wang R, Cui J, Li W, Yang X, Yao Z

This study shows that a specific RNA network involving IDI2-AS1, miR-33b-5p, and NR4A2 plays a key role in heart damage after a heart attack. Boosting miR-33b-5p reduces heart scarring, inflammation, and cell death by lowering NR4A2 levels, suggesting a potential pathway to protect the heart.

• NR4A2 is increased after heart attacks and linked to worse outcomes
• miR-33b-5p reduces heart damage by lowering NR4A2
• Boosting miR-33b-5p improves heart function and reduces scarring
• The IDI2-AS1/miR-33b-5p/NR4A2 network is a key regulator of heart injury
• Targeting this pathway may offer new treatments for heart attacks

Single-nucleus multiomics unravels the genetic mechanisms underlying musk secretion in Chinese forest musk deer (Moschus berezovskii).

Liu C, Hong T, Yu L, Chen Y, Dong X, Ren Z

This study identifies key genes and regulatory proteins involved in musk secretion in deer, including NR4A2, which plays a role in controlling the process. The findings reveal specific molecular pathways, such as steroid hormone biosynthesis and GnRH signaling, that drive musk production.

• NR4A2 is involved in regulating musk secretion in deer
• Steroid hormone biosynthesis is active in musk-producing cells
• GnRH signaling pathway is critical for musk production
• Cell communication helps maintain musk secretion
• Findings may help improve musk yield or treat related disorders

NR4A ablation improves mitochondrial fitness for long persistence in human CAR-T cells against solid tumors.

Nakagawara K, Ando M, Srirat T, Mise-Omata S, Hayakawa T, Ito M, Fukunaga K, Yoshimura A

Deleting NR4A genes in human T cells improves their ability to fight solid tumors by preventing exhaustion and enhancing mitochondrial function. This research focuses on cancer immunotherapy and does not provide information relevant to NR4A2-related neurodevelopmental syndromes.

• NR4A deletion prevents T-cell exhaustion in human CAR-T therapies for solid tumors.
• Enhanced mitochondrial fitness allows modified T cells to persist longer in tumor environments.
• This study addresses cancer treatment, not NR4A2-related neurological conditions.

Author Correction: The Nurr1 ligand indole acetic acid hydrazide loaded onto ZnFe2O4 nanoparticles suppresses proinflammatory gene expressions in SimA9 microglial cells.

Qasim R, Thiab TA, Alhindi T, Al-Hunaiti A, Imraish A

This study demonstrates that a specific compound attached to nanoparticles reduces inflammatory signals in cultured microglial cells. The research focuses on cellular mechanisms of inflammation rather than human health outcomes or genetic therapies for NR4A2-related conditions.

• The study uses engineered nanoparticles to deliver an anti-inflammatory compound.
• Results show suppressed proinflammatory gene expression in a specific microglial cell line.
• No human data, animal models, or NR4A2 genetic interactions are reported.
• Findings are limited to basic cellular biology and do not suggest clinical treatments.

CCL22 Induces the Polarization of Immature Dendritic Cells into Tolerogenic Dendritic Cells in Radiation-Induced Lung Injury through the CCR4-Dectin2-PLC-γ2-NFATC2-Nr4a2-PD-L1 Signaling Pathway.

Liu B, Wang Y, Ma L, Chen G, Yang Z, Zhu M

This study identifies a specific immune signaling pathway in lung tissue where the protein Nr4a2 helps regulate inflammation after radiation exposure. The research focuses entirely on how immune cells respond to physical injury in mice and cell cultures, with no connection to brain development or neurological function.

• The study uses mouse models of radiation-induced lung injury, not human patients.
• Nr4a2 functions within an immune pathway regulating dendritic cell tolerance in the lungs.
• No findings relate to dopaminergic neurons, neurodevelopment, or NR4A2 syndrome phenotypes.
• Results describe molecular mechanisms in non-neural tissues with no clinical application for this child.

Potential effects of Resatorvid and alpha lipoic acid on gentamicin-induced nephrotoxicity in rats.

Dik B, Hatipoglu D, Ates MB

Resatorvid and alpha lipoic acid reduce kidney damage from gentamicin in rats by lowering key injury markers and inflammatory signals, with Resatorvid showing stronger effects on inflammation pathways.

• Resatorvid and ALA reduce kidney injury markers in rats
• Resatorvid lowers inflammation more effectively than ALA
• Both treatments reduce oxidative stress and cell death signals
• NR4A2 levels dropped with both treatments
• Findings may help protect kidneys during long-term gentamicin use

Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism.

Willems S, Busch R, Nawa F, Ballarotto M, Lillich FF, Kasch T, López-García Ú, Marschner JA, Rüger LA, Renelt B, Ohrndorf J, Arifi S, Zaienne D, Proschak E, Pabel J, Merk D

Researchers optimized the drug oxaprozin to selectively target and inhibit the NR4A2 protein. This work creates a new molecular tool for studying NR4A2 function in laboratory settings.

• The study modifies oxaprozin to specifically block NR4A2 activity.
• It distinguishes between effects on NR4A2 and related RXR receptors.
• The resulting compound is a potent, selective inverse agonist for NR4A2.
• This provides a research tool for mechanistic studies in cell models.

The roles of orphan nuclear receptor 4 group A1 and A2 in fibrosis.

Gao L, Wang H, Fang F, Liu J, Zhao C, Niu J, Wang Z, Zhong Y, Wang X

This review summarizes how NR4A1 and NR4A2 inhibit fibrosis by blocking TGF-β signaling and reducing collagen deposition in various organs. It provides a general overview of these receptors' roles in tissue repair but does not address NR4A2-related syndromes or neurological outcomes.

• NR4A1 and NR4A2 inhibit fibrosis by blocking TGF-β signaling pathways.
• Overexpression reduces collagen deposition and fibrosis-related gene expression.
• The paper reviews mechanisms in kidney, liver, lung, heart, and skin.
• It does not discuss NR4A2 syndrome, neurology, or human clinical data.

The complex association between the immune system and the skeletal system in osteoporosis: A study of single-cell RNA sequencing.

Yang W, Wang M, Hu J, Mo K, Xie X

This study used single-cell RNA sequencing to identify specific immune and bone cells involved in osteoporosis, finding that certain immune cells worsen bone loss by creating inflammation, while others help protect bone. It also revealed key communication pathways between bone and immune cells that could be targeted for new treatments.

• Certain immune cells drive bone loss by causing inflammation
• Some immune and bone cells help maintain bone balance
• Specific cell communication pathways link immune and bone cells
• Findings may lead to more precise osteoporosis treatments

Genoarchitectural Definition of the Adult Mouse Mesocortical Ring: A Contribution to Cortical Ring Theory.

Puelles L, Alonso A, García-Calero E

This study uses mouse brain data to redefine the molecular boundaries of specific cortical regions. It identifies Nr4a2 as a marker for parahippocampal allocortex rather than mesocortex, correcting previous anatomical classifications in mice.

• Researchers analyzed adult mouse brain gene expression databases to map cortical areas.
• The study identified 46 specific genetic markers defining the mesocortex region.
• Nr4a2 is shown to mark parahippocampal allocortex, not mesocortex in this context.
• The retrosplenial area is reclassified based on its distinct molecular profile.
• Findings refine the understanding of mouse cortical structure and connectivity.

Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis.

Yu R, Huang Y, Hu X, Chen J

This bioinformatic study identifies NR4A2 as one of several genes dysregulated in non-alcoholic fatty liver disease (NAFLD) and correlates its expression with immune system activity in the liver. The research focuses entirely on liver pathology and does not investigate the role of NR4A2 in brain development or neurological function.

• NR4A2 appears as a biomarker for NAFLD, a liver disease unrelated to NR4A2 syndrome.
• The study uses computational analysis of existing gene expression datasets from liver tissue.
• No clinical data, patient phenotypes, or neurological mechanisms are examined.
• Findings do not inform treatment or understanding of NR4A2-related neurodevelopmental disorders.

iPSC-Derived Astrocytes and Neurons Replicate Brain Gene Expression, Epigenetic, Cell Morphology and Connectivity Alterations Found in Autism.

Mostafavi Abdolmaleky H, Alam R, Nohesara S, Deth RC, Zhou JR

This study identifies reduced expression of the NR4A2 gene (NURR1) in brain cells derived from individuals with autism, alongside broader inflammatory and epigenetic changes. These findings replicate postmortem brain data, confirming that patient-derived cell models accurately mirror disease-associated molecular alterations.

• NR4A2 expression decreases in astrocytes from patients with autism.
• The study uses iPSC-derived cells to model autism-related brain changes.
• Inflammatory markers and epigenetic modifications also show significant alterations.
• Cell models replicate postmortem brain findings, validating their use for research.

The NR4A2/VGF pathway fuels inflammation-induced neurodegeneration via promoting neuronal glycolysis.

Woo MS, Bal LC, Winschel I, Manca E, Walkenhorst M, Sevgili B, Sonner JK, Di Liberto G, Mayer C, Binkle-Ladisch L, Rothammer N, Unger L, Raich L, Hadjilaou A, Noli B, Manai AL, Vieira V, Meurs N, Wagner I, Pless O, Cocco C, Stephens SB, Glatzel M, Merkler D, Friese MA

The study identifies a mechanism where NR4A2 drives neuronal death in multiple sclerosis by increasing glycolysis and VGF secretion. While this pathway is harmful in inflammatory contexts like MS, the research does not provide direct evidence for treating NR4A2-related developmental syndromes.

• NR4A2 promotes neuronal cell death via increased glycolysis and VGF secretion.
• VGF levels are elevated in serum and brain biopsies of people with MS.
• Deleting Vgf in mice reduces neurodegeneration in a multiple sclerosis model.
• The findings link excitatory activity to metabolic shifts causing neuron loss.

The Nurr1 ligand indole acetic acid hydrazide loaded onto ZnFe2O4 nanoparticles suppresses proinflammatory gene expressions in SimA9 microglial cells.

Qasim R, Thiab TA, Alhindi T, Al-Hunaiti A, Imraish A

This study shows that a specific chemical compound loaded onto nanoparticles reduces inflammatory signals in cultured mouse microglial cells by targeting the Nurr1 protein. The findings are limited to cell culture experiments and do not provide evidence of safety or efficacy in humans.

• Researchers tested a nanoparticle-delivered compound on mouse immune cells in a dish.
• The treatment successfully lowered levels of three major pro-inflammatory markers.
• The effect occurred by activating the Nurr1 receptor to suppress inflammation.
• No human data, animal models, or clinical outcomes are reported here.

Gangliosides in neural stem cell fate determination and nerve cell specification--preparation and administration.

Itokazu Y, Ariga T, Fuchigami T, Li D

This preprint describes how gangliosides GD3 and GM1 support neural stem cell survival and promote neuronal differentiation, including the specific induction of dopaminergic neuron markers like tyrosine hydroxylase via Nurr1 recruitment. It provides a technical protocol for isolating these lipids and administering them into mouse brains to study their effects on nerve cell specification.

• GD3 administration restores neural stem cell pools and improves behavioral deficits in knockout mice.
• GM1 promotes neuronal differentiation through epigenetic mechanisms involving histone acetylation.
• GM1 recruits Nurr1 and PITX3 to the tyrosine hydroxylase promoter, aiding dopaminergic specification.
• The study offers methods for isolating GD3/GM1 and injecting them into mouse brains.

Transcription Factor-Mediated Generation of Dopaminergic Neurons from Human iPSCs-A Comparison of Methods.

McDonald KO, Lyons NMA, Gray LKC, Xu JB, Schoderboeck L, Hughes SM, Basak I

Researchers develop a faster, cheaper method to create dopaminergic neurons from human stem cells using transcription factors and small molecules. This technique generates a high percentage of mature dopaminergic neurons in just three weeks compared to the two months required by previous methods.

• The study compares three protocols for generating dopaminergic neurons from human iPSCs.
• A new method uses lentivirus transduction to integrate transcription factors into a safe genomic locus.
• This approach produces over 85% dopaminergic neurons within three weeks.
• Combining transcription factors with small molecules yields a purer population of target neurons.

Impact of food additives on neurodevelopmental processes in zebrafish (Danio rerio): Exploring circadian clock genes and dopamine system.

Christy LD, Vignesh K, Nellore J, Tippabathani J

Exposure to common food additives disrupts circadian and dopamine-related genes in zebrafish, leading to neurodevelopmental toxicity. These findings suggest potential risks for human neurodevelopment during critical early life stages.

• Food additives alter NURR1 and dopamine genes in zebrafish embryos.
• Additives cause reduced locomotor activity and heart rate changes in larvae.
• Neurobehavioral effects link circadian clock disruption to dopamine system dysfunction.
• Study highlights neurodevelopmental risks from dietary additives during early development.

Endocrine toxicity of atrazine and its underlying mechanisms.

Zhao H, Qian H, Cui J, Ge Z, Shi J, Huo Y, Zhang Y, Ye L

Atrazine, a common herbicide, disrupts the endocrine system by interfering with hormone regulation, dopamine function, and metabolic processes, potentially affecting development and neurological health. Natural compounds like melatonin and curcumin may help reduce its toxic effects.

• Atrazine harms hormone systems and brain chemistry
• It disrupts dopamine and metabolic function
• Natural antioxidants may help counteract its effects
• Most evidence comes from lab studies, not human populations

RETRACTION: Mechanism of ARPP21 antagonistic intron miR-128 on neurological function repair after stroke.

This paper has been retracted due to image duplication from other studies and lack of response from the authors, making the data unreliable and unusable for any clinical or research purposes.

• The study was retracted due to image plagiarism
• Authors did not provide original data or explanations
• Findings cannot be trusted or used for research
• No valid conclusions about neurological repair after stroke

Expression of G2019S LRRK2 in Rat Primary Astrocytes Mediates Neurotoxicity and Alters the Dopamine Synthesis Pathway in N27 Cells via Astrocytic Proinflammatory Cytokines and Neurotrophic Factors.

Ho DH, Kim H, Nam D, Seo MK, Park SW, Son I

Mutant LRRK2 in rat astrocytes triggers inflammation and reduces neurotrophic support, which subsequently impairs dopamine synthesis and release in dopaminergic cells. This study highlights a specific mechanism by which glial dysfunction can disrupt the dopamine pathway relevant to movement disorders.

• Mutant LRRK2 in rat astrocytes increases proinflammatory cytokines and decreases nerve growth factor.
• Conditioned medium from these astrocytes reduces viability of dopaminergic N27 cells.
• Dopamine synthesis pathway is altered, affecting tyrosine hydroxylase and dopamine transporter levels.
• Nurr1 (NR4A2) expression is reduced in dopaminergic cells exposed to mutant astrocyte medium.
• The study uses rat primary astrocytes and cell lines, not human patients or NR4A2 mutations.

Corrigendum to "Nurr1: A vital participant in the TLR4-NF-κB signal pathway stimulated by a-synuclein in BV-2 cells" [Neuropharmacol. (2019) 144 388-399] doi:10.1016/j.neuropharm.2018.04.008.

Shao QH, Yan WF, Zhang Z, Ma KL, Peng SY, Cao YL, Yuan YH, Chen NH

This corrigendum corrects a previous study on how alpha-synuclein activates immune signaling in mouse microglial cells. It does not provide new findings relevant to human NR4A2-related syndromes or clinical treatment.

• The paper is a correction to a prior publication, not a new study.
• It investigates TLR4-NF-kB signaling in BV-2 mouse microglial cells.
• Alpha-synuclein stimulates this pathway in the cell model used.
• No human data or NR4A2 genetic findings are included.
• The research focuses on basic cellular mechanisms unrelated to patient care.

Differentiation of neural stem cells from human olfactory mucosa into dopaminergic neuron-like cells.

Ertem T, Uysal O

Researchers successfully convert stem cells from human nasal tissue into dopamine-producing neuron-like cells in a laboratory dish. This process confirms that these specific stem cells can generate the cell type relevant to dopaminergic disorders, though it remains an early-stage experimental finding.

• Stem cells are harvested from human olfactory mucosa (nasal tissue).
• Cells differentiate into neuron-like cells expressing dopamine markers in vitro.
• The study focuses on Parkinson's disease cell replacement strategies.
• No clinical trials or patient data are included in this work.

Albiflorin ameliorates thioacetamide-induced hepatic fibrosis: The involvement of NURR1-mediated inflammatory signaling cascades in hepatic stellate cells activation.

Song J, Qin BF, Feng QY, Zhang JJ, Zhao GY, Luo Z, Sun HM

Albiflorin reduces liver scarring in mice by activating NURR1, a protein linked to inflammation control, which helps calm overactive liver cells and immune cells involved in liver damage. This suggests a potential treatment path for liver fibrosis, though the findings are in animal models.

• Albiflorin reduces liver scarring in mice
• It works by boosting NURR1 activity
• NURR1 helps control harmful inflammation in liver cells
• The effect involves communication between liver and immune cells
• Findings are from a mouse model of liver disease